rs17003955

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012282.4(KCNE5):​c.97C>T​(p.Pro33Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 1,193,881 control chromosomes in the GnomAD database, including 8,816 homozygotes. There are 53,401 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 595 hom., 3183 hem., cov: 24)
Exomes 𝑓: 0.14 ( 8221 hom. 50218 hem. )

Consequence

KCNE5
NM_012282.4 missense

Scores

1
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.180

Publications

16 publications found
Variant links:
Genes affected
KCNE5 (HGNC:6241): (potassium voltage-gated channel subfamily E regulatory subunit 5) This gene encodes a member of a family of single pass transmembrane domain proteins that function as ancillary subunits to voltage-gated potassium channels. Members of this family affect diverse processes in potassium channel regulation, including ion selectivity, voltage dependence, and anterograde recycling from the plasma membrane. Variants of this gene are associated with idiopathic ventricular fibrillation and Brugada syndrome. [provided by RefSeq, Nov 2016]
ACSL4 (HGNC:3571): (acyl-CoA synthetase long chain family member 4) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the cognitive disability or Alport syndrome. Alternative splicing of this gene generates multiple transcript variants. [provided by RefSeq, Jan 2016]
ACSL4 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: ClinGen, Illumina, Orphanet
  • intellectual disability, X-linked 63
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001214087).
BP6
Variant X-109624924-G-A is Benign according to our data. Variant chrX-109624924-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 381189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE5NM_012282.4 linkc.97C>T p.Pro33Ser missense_variant Exon 1 of 1 ENST00000372101.3 NP_036414.1 Q9UJ90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE5ENST00000372101.3 linkc.97C>T p.Pro33Ser missense_variant Exon 1 of 1 6 NM_012282.4 ENSP00000361173.2 Q9UJ90
ACSL4ENST00000439581.1 linkn.387-603C>T intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.0996
AC:
11224
AN:
112675
Hom.:
595
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0200
Gnomad AMI
AF:
0.0694
Gnomad AMR
AF:
0.0663
Gnomad ASJ
AF:
0.207
Gnomad EAS
AF:
0.00113
Gnomad SAS
AF:
0.0486
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.170
Gnomad NFE
AF:
0.155
Gnomad OTH
AF:
0.0965
GnomAD2 exomes
AF:
0.109
AC:
15962
AN:
145818
AF XY:
0.114
show subpopulations
Gnomad AFR exome
AF:
0.0189
Gnomad AMR exome
AF:
0.0490
Gnomad ASJ exome
AF:
0.198
Gnomad EAS exome
AF:
0.000174
Gnomad FIN exome
AF:
0.126
Gnomad NFE exome
AF:
0.167
Gnomad OTH exome
AF:
0.130
GnomAD4 exome
AF:
0.143
AC:
155001
AN:
1081162
Hom.:
8221
Cov.:
32
AF XY:
0.143
AC XY:
50218
AN XY:
351456
show subpopulations
African (AFR)
AF:
0.0174
AC:
451
AN:
25992
American (AMR)
AF:
0.0517
AC:
1717
AN:
33223
Ashkenazi Jewish (ASJ)
AF:
0.200
AC:
3837
AN:
19169
East Asian (EAS)
AF:
0.000206
AC:
6
AN:
29146
South Asian (SAS)
AF:
0.0599
AC:
3104
AN:
51803
European-Finnish (FIN)
AF:
0.121
AC:
4456
AN:
36919
Middle Eastern (MID)
AF:
0.136
AC:
529
AN:
3888
European-Non Finnish (NFE)
AF:
0.161
AC:
134804
AN:
835550
Other (OTH)
AF:
0.134
AC:
6097
AN:
45472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
5830
11659
17489
23318
29148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4848
9696
14544
19392
24240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0996
AC:
11223
AN:
112719
Hom.:
595
Cov.:
24
AF XY:
0.0912
AC XY:
3183
AN XY:
34917
show subpopulations
African (AFR)
AF:
0.0200
AC:
625
AN:
31277
American (AMR)
AF:
0.0663
AC:
720
AN:
10865
Ashkenazi Jewish (ASJ)
AF:
0.207
AC:
548
AN:
2643
East Asian (EAS)
AF:
0.00113
AC:
4
AN:
3531
South Asian (SAS)
AF:
0.0495
AC:
138
AN:
2789
European-Finnish (FIN)
AF:
0.118
AC:
735
AN:
6205
Middle Eastern (MID)
AF:
0.177
AC:
38
AN:
215
European-Non Finnish (NFE)
AF:
0.155
AC:
8221
AN:
52974
Other (OTH)
AF:
0.0953
AC:
147
AN:
1543
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
336
672
1009
1345
1681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.132
Hom.:
4963
Bravo
AF:
0.0924
ESP6500AA
AF:
0.0167
AC:
63
ESP6500EA
AF:
0.142
AC:
946
ExAC
AF:
0.105
AC:
12265

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brugada syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.3
DANN
Benign
0.76
DEOGEN2
Benign
0.060
T
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.0012
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.18
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.80
N
REVEL
Benign
0.072
Sift
Benign
0.41
T
Sift4G
Benign
0.082
T
Polyphen
0.0010
B
Vest4
0.018
MPC
0.38
ClinPred
0.0060
T
GERP RS
1.0
PromoterAI
0.013
Neutral
Varity_R
0.035
gMVP
0.62
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17003955; hg19: chrX-108868153; COSMIC: COSV107461736; COSMIC: COSV107461736; API